111 related articles for article (PubMed ID: 20235612)
1. Dynamics and attenuation of acidic pharmaceuticals along a river stretch.
Radke M; Ulrich H; Wurm C; Kunkel U
Environ Sci Technol; 2010 Apr; 44(8):2968-74. PubMed ID: 20235612
[TBL] [Abstract][Full Text] [Related]
2. Determination of phenolic endocrine disrupting chemicals and acidic pharmaceuticals in surface water of the Pearl Rivers in South China by gas chromatography-negative chemical ionization-mass spectrometry.
Zhao JL; Ying GG; Wang L; Yang JF; Yang XB; Yang LH; Li X
Sci Total Environ; 2009 Jan; 407(2):962-74. PubMed ID: 19004474
[TBL] [Abstract][Full Text] [Related]
3. Occurrence and risk assessment of acidic pharmaceuticals in the Yellow River, Hai River and Liao River of north China.
Wang L; Ying GG; Zhao JL; Yang XB; Chen F; Tao R; Liu S; Zhou LJ
Sci Total Environ; 2010 Jul; 408(16):3139-47. PubMed ID: 20493517
[TBL] [Abstract][Full Text] [Related]
4. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden.
Bendz D; Paxéus NA; Ginn TR; Loge FJ
J Hazard Mater; 2005 Jul; 122(3):195-204. PubMed ID: 15967274
[TBL] [Abstract][Full Text] [Related]
5. Reactive tracer test to evaluate the fate of pharmaceuticals in rivers.
Kunkel U; Radke M
Environ Sci Technol; 2011 Aug; 45(15):6296-302. PubMed ID: 21671643
[TBL] [Abstract][Full Text] [Related]
6. Fate of pharmaceuticals in rivers: Deriving a benchmark dataset at favorable attenuation conditions.
Kunkel U; Radke M
Water Res; 2012 Nov; 46(17):5551-5565. PubMed ID: 22898670
[TBL] [Abstract][Full Text] [Related]
7. Occurrence and behavior of non-steroidal anti-inflammatory drugs and lipid regulators in wastewater and urban river water of the Pearl River Delta, South China.
Huang Q; Yu Y; Tang C; Zhang K; Cui J; Peng X
J Environ Monit; 2011 Apr; 13(4):855-63. PubMed ID: 21412553
[TBL] [Abstract][Full Text] [Related]
8. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada.
Lishman L; Smyth SA; Sarafin K; Kleywegt S; Toito J; Peart T; Lee B; Servos M; Beland M; Seto P
Sci Total Environ; 2006 Aug; 367(2-3):544-58. PubMed ID: 16697441
[TBL] [Abstract][Full Text] [Related]
9. Fate of pharmaceuticals--photodegradation by simulated solar UV-light.
Doll TE; Frimmel FH
Chemosphere; 2003 Sep; 52(10):1757-69. PubMed ID: 12871743
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters.
Lindqvist N; Tuhkanen T; Kronberg L
Water Res; 2005 Jun; 39(11):2219-28. PubMed ID: 15935437
[TBL] [Abstract][Full Text] [Related]
11. Fate of beta-blocker human pharmaceuticals in surface water: comparison of measured and simulated concentrations in the Glatt Valley Watershed, Switzerland.
Alder AC; Schaffner C; Majewsky M; Klasmeier J; Fenner K
Water Res; 2010 Feb; 44(3):936-48. PubMed ID: 19889439
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada.
Boyd GR; Reemtsma H; Grimm DA; Mitra S
Sci Total Environ; 2003 Jul; 311(1-3):135-49. PubMed ID: 12826389
[TBL] [Abstract][Full Text] [Related]
13. Determination of acidic pharmaceuticals and potential endocrine disrupting compounds in wastewaters and spring waters by selective elution and analysis by gas chromatography-mass spectrometry.
Gibson R; Becerril-Bravo E; Silva-Castro V; Jiménez B
J Chromatogr A; 2007 Oct; 1169(1-2):31-9. PubMed ID: 17884063
[TBL] [Abstract][Full Text] [Related]
14. Seasonal variations in the occurrence and fate of basic and neutral pharmaceuticals in a Swedish river-lake system.
Daneshvar A; Svanfelt J; Kronberg L; Prévost M; Weyhenmeyer GA
Chemosphere; 2010 Jun; 80(3):301-9. PubMed ID: 20430415
[TBL] [Abstract][Full Text] [Related]
15. An investigation into the acute and chronic toxicity of eleven pharmaceuticals (and their solvents) found in wastewater effluent on the cnidarian, Hydra attenuata.
Quinn B; Gagné F; Blaise C
Sci Total Environ; 2008 Jan; 389(2-3):306-14. PubMed ID: 17931692
[TBL] [Abstract][Full Text] [Related]
16. The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK.
Kasprzyk-Hordern B; Dinsdale RM; Guwy AJ
Water Res; 2008 Jul; 42(13):3498-518. PubMed ID: 18514758
[TBL] [Abstract][Full Text] [Related]
17. Occurrence of endocrine disrupting compounds, pharmaceuticals, and personal care products in the Han River (Seoul, South Korea).
Yoon Y; Ryu J; Oh J; Choi BG; Snyder SA
Sci Total Environ; 2010 Jan; 408(3):636-43. PubMed ID: 19900699
[TBL] [Abstract][Full Text] [Related]
18. Pharmaceutical compounds in the wastewater process stream in Northwest Ohio.
Spongberg AL; Witter JD
Sci Total Environ; 2008 Jul; 397(1-3):148-57. PubMed ID: 18396321
[TBL] [Abstract][Full Text] [Related]
19. Loadings, trends, comparisons, and fate of achiral and chiral pharmaceuticals in wastewaters from urban tertiary and rural aerated lagoon treatments.
MacLeod SL; Wong CS
Water Res; 2010 Jan; 44(2):533-44. PubMed ID: 19854463
[TBL] [Abstract][Full Text] [Related]
20. Persistence and partitioning of eight selected pharmaceuticals in the aquatic environment: laboratory photolysis, biodegradation, and sorption experiments.
Yamamoto H; Nakamura Y; Moriguchi S; Nakamura Y; Honda Y; Tamura I; Hirata Y; Hayashi A; Sekizawa J
Water Res; 2009 Feb; 43(2):351-62. PubMed ID: 19041113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
